Trader’s Watch List: Amicus Therapeutics, Inc. (NASDAQ:FOLD), Chesapeake Energy Corporation (NYSE:CHK), Envivio, Inc. (NASDAQ:ENVI), Mannatech, Incorporated (NASDAQ:MTEX), Endocyte, Inc. (NASDAQ:ECYT)

Amicus Therapeutics (NASDAQ:FOLD) COO Bradley L. Campbell unloaded 18,750 shares of the company’s stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $5.40, for a total transaction of $101,250.00. Following the completion of the transaction, the chief operating officer now directly owns 200,000 shares in the company, valued at approximately $1,080,000. Amicus Therapeutics, Inc. (NASDAQ:FOLD) … Continue reading Trader’s Watch List: Amicus Therapeutics, Inc. (NASDAQ:FOLD), Chesapeake Energy Corporation (NYSE:CHK), Envivio, Inc. (NASDAQ:ENVI), Mannatech, Incorporated (NASDAQ:MTEX), Endocyte, Inc. (NASDAQ:ECYT)

Top Gainers: USEC Inc. (NYSE:USU), Voxeljet (NYSE:VJET), Arista Networks Inc (NYSE:ANET), Amicus Therapeutics (NASDAQ:FOLD), Everyware Global (NASDAQ:EVRY)

USEC Inc. (NYSE:USU) closed up 143.89% today after news of its 8-K filing with the Securities and Exchange Commission (SEC) regarding new funding, of $2.5 million, from the US Department of Energy (DOE). The funding comes following an amendment to an agreement with a research lab operator for further research on American Centrifuge technology. USEC Inc. (NYSE:USU) stock performance was 143.89% in last session and … Continue reading Top Gainers: USEC Inc. (NYSE:USU), Voxeljet (NYSE:VJET), Arista Networks Inc (NYSE:ANET), Amicus Therapeutics (NASDAQ:FOLD), Everyware Global (NASDAQ:EVRY)

Healthcare Most Active Stocks: MannKind Corporation (NASDAQ:MNKD), Pfizer Inc. (NYSE:PFE), Amicus Therapeutics (NASDAQ:FOLD), Geron Corporation (NASDAQ:GERN), Gilead Sciences (NASDAQ:GILD)

MannKind Corporation (NASDAQ:MNKD) VP David Thomson sold 30,000 shares of the stock on the open market in a transaction that occurred on Thursday, June 26th. The shares were sold at an average price of $10.51, for a total transaction of $315,300.00. Following the transaction, the vice president now directly owns 102,286 shares in the company, valued at approximately $1,075,026. MannKind Corporation (NASDAQ:MNKD) stock performance was … Continue reading Healthcare Most Active Stocks: MannKind Corporation (NASDAQ:MNKD), Pfizer Inc. (NYSE:PFE), Amicus Therapeutics (NASDAQ:FOLD), Geron Corporation (NASDAQ:GERN), Gilead Sciences (NASDAQ:GILD)

Healthcare Most Active Stocks: MannKind Corporation (NASDAQ:MNKD), Pfizer Inc. (NYSE:PFE), Amicus Therapeutics (NASDAQ:FOLD), Geron Corporation (NASDAQ:GERN), Gilead Sciences (NASDAQ:GILD)

MannKind Corporation (NASDAQ:MNKD) VP David Thomson sold 30,000 shares of the stock on the open market in a transaction that occurred on Thursday, June 26th. The shares were sold at an average price of $10.51, for a total transaction of $315,300.00. Following the transaction, the vice president now directly owns 102,286 shares in the company, valued at approximately $1,075,026. MannKind Corporation (NASDAQ:MNKD) stock performance was … Continue reading Healthcare Most Active Stocks: MannKind Corporation (NASDAQ:MNKD), Pfizer Inc. (NYSE:PFE), Amicus Therapeutics (NASDAQ:FOLD), Geron Corporation (NASDAQ:GERN), Gilead Sciences (NASDAQ:GILD)

Biotech Decliners: Amicus Therapeutics, Inc. (NASDAQ:FOLD), Relypsa Inc (NASDAQ:RLYP), Receptos Inc (NASDAQ:RCPT), TG Therapeutics, Inc. (NASDAQ:TGTX), Chimerix Inc (NASDAQ:CMRX)

On May 9, 2014, Amicus Therapeutics, Inc. (NASDAQ:FOLD) updated its Investor Presentation for the Migalastat Monotherapy Program (the “Presentation”). The Company’s Chief Financial Officer, William D. Baird III and the Company’s Chief Operating Officer, Bradley L. Campbell, will present some or all of this Presentation to various investors in the coming months. A copy of the presentation materials is attached hereto as Exhibit 99.1. Amicus … Continue reading Biotech Decliners: Amicus Therapeutics, Inc. (NASDAQ:FOLD), Relypsa Inc (NASDAQ:RLYP), Receptos Inc (NASDAQ:RCPT), TG Therapeutics, Inc. (NASDAQ:TGTX), Chimerix Inc (NASDAQ:CMRX)